A Phase I-II Multicenter Trial with Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-Treated Mismatch Repair-Proficient (MSS) Metastatic Colorectal Cancer Patients; GEMCAD 1602 Study
Cancer immunology, immunotherapy/Cancer immunology and immunotherapy(2022)
关键词
Vaccines,Metabolism,Resistance
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要